CSMD1 is one of several genes that are typically overexpressed in monocytes in prostate cancer and has been suggested as a biomarker differentiating prostate cancer from benign prostatic hyperplasia [43]. The gene discussed is CSMD1; the disease is Familial prostate cancer.